Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | KRYS | ALKS | ||
| Company | Ultragenyx Pharmaceu | Krystal Biotech Inc | Alkermes Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 58.72 | 190.02 | 27.76 | ||
| High | 58.96 | 190.84 | 28.39 | ||
| Low | 57.44 | 182.18 | 27.62 | ||
| Last | 57.70 | 182.74 | 27.83 | ||
| Change | -0.79 | -6.52 | +0.09 | ||
| % Change | -1.35% | -3.44% | +0.32% | ||
| Volume | 495,313 | 334,975 | 1,401,869 | ||
| 20-Day Average Volume | 643,416 | 229,314 | 1,369,738 | ||
| Previous Close | 58.49 | 189.26 | 27.74 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 56.99 | 193.58 | 27.69 | ||
| 20-Day Raw Stochastic | 62.87% | 5.39% | 71.76% | ||
| 20-Day Relative Strength | 63.40% | 44.46% | 55.80% | ||
| Weighted Alpha | +64.11 | +25.31 | +1.10 | ||
| Today's Opinion | 88% Buy | 40% Buy | 72% Buy | ||
| Previous Opinion | 88% Buy | 48% Buy | 72% Buy | ||
| Last Month's Opinion | 72% Buy | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.43% since 09/11/24 | -8.07% since 09/11/24 | +4.74% since 09/11/24 | ||
| Low | 56.14 on 09/12/24 | 182.18 on 09/18/24 | 26.01 on 09/12/24 | ||
| High | 60.37 on 09/16/24 | 203.29 on 09/16/24 | 28.47 on 09/17/24 | ||
| 1-Month | |||||
| %Chg | +8.77% since 08/16/24 | -5.02% since 08/16/24 | +2.13% since 08/16/24 | ||
| Low | 52.63 on 08/20/24 | 181.36 on 09/06/24 | 25.65 on 09/10/24 | ||
| High | 60.37 on 09/16/24 | 206.97 on 08/28/24 | 28.69 on 08/27/24 | ||
| 3-Month | |||||
| %Chg | +54.20% since 06/18/24 | +5.63% since 06/18/24 | +13.96% since 06/18/24 | ||
| Low | 37.27 on 06/20/24 | 164.81 on 08/05/24 | 22.90 on 07/10/24 | ||
| High | 60.37 on 09/16/24 | 219.34 on 07/26/24 | 28.95 on 07/26/24 | ||
| 6-Month | |||||
| %Chg | +23.85% since 03/18/24 | +8.43% since 03/18/24 | +1.09% since 03/18/24 | ||
| Low | 37.02 on 06/18/24 | 144.00 on 05/06/24 | 22.90 on 07/10/24 | ||
| High | 60.37 on 09/16/24 | 219.34 on 07/26/24 | 28.95 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,862,450 | 5,404,887 | 4,694,191 | ||
| Shares Outstanding, K | 83,133 | 28,558 | 169,221 | ||
| Annual Sales | 434,250,000 | 50,700,000 | 1,663,410,000 | ||
| Annual Net Income | -606,640,000 | 10,930,000 | 355,760,000 | ||
| Last Quarter Sales | 147,030,000 | 70,280,000 | 399,130,000 | ||
| Last Quarter Net Income | -131,600,000 | 15,570,000 | 91,360,000 | ||
| 60-Month Beta | 0.56 | 0.82 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.52 on 08/01/24 | 0.86 on 08/05/24 | 0.72 on 07/24/24 | ||
| Latest Earnings Date | 11/07/24 | 11/04/24 | 10/23/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 373.60 | 16.09 | ||